ClinicalTrials.gov
ClinicalTrials.gov Menu

BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (BIANCA-SC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01598857
Recruitment Status : Withdrawn
First Posted : May 15, 2012
Last Update Posted : July 30, 2015
Sponsor:
Information provided by (Responsible Party):
Anthera Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2015
  Study Completion Date : No date given